- The drug is the first of several long-acting antiretroviral HIV drugs in development- Researchers hope it will ensure that drugs that can prevent the virus from replicating in their cells are taken consistently by individualsPAY ATTENTION: Join TUKO.co.ke Telegram channel! Never miss important updatesThe US Food and Drug Administration has approved a new Human Immunodeficiency Virus (HIV) drug which could see patients stop taking daily antiretroviral therapy drugs. The new HIV drug could see patients stop taking daily antiretroviral therapy drugs. The drug is the first of several long-acting antiretroviral HIV drugs in development, which researchers hope will ensure that drugs that can prevent the virus from replicating in their cells are taken consistently by individuals. Before starting treatment with Cabenuva, oral doses of cabotegravir and rilpivirine (lead-in) were administered to the participants for approximately one month to assess the tolerability of each treatment.

Source: Daily Nation January 26, 2021 19:10 UTC